Immuron (IMRN) Short term Debt (2016 - 2023)
Immuron (IMRN) posted quarterly Short term Debt of $5.4 million for Q2 2023, up 93.71% on a QoQ basis from $2.8 million in Q2 2021.
Immuron (IMRN) Short term Debt (2016 - 2023) Analysis & Trends
Immuron (IMRN) has reported Short term Debt for 7 consecutive years, with $5.4 million the latest figure, recorded in Q2 2023.
- Quarterly Short term Debt changed N/A year-over-year to $5.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $5.4 million (changed N/A YoY) and the FY2020 annual result came in at $2.1 million, down 42.34% from the prior year.
- Short term Debt climbed to $5.4 million in Q2 2023 per IMRN's latest filing, from $2.8 million in the prior quarter.
- Over the last five years, Short term Debt for IMRN reached as high as $5.4 million in Q2 2023 and fell as low as $98120.0 in Q4 2019.
- A 4-year average of $3.1 million and a median of $2.8 million in 2021 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2020 — Short term Debt slumped 59.28% — and 2021, when it soared 30.15%.
- Year by year, Short term Debt stood at $98120.0 in 2019, then surged by 2080.95% to $2.1 million in 2020, then soared by 30.15% to $2.8 million in 2021, then soared by 93.71% to $5.4 million in 2023.
- According to Business Quant data, Short term Debt over the past three periods registered $5.4 million, $2.8 million, and $2.1 million for Q2 2023, Q2 2021, and Q2 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 5.39 Mn |
| Jun 30, 2021 | 2.79 Mn |
| Jun 30, 2020 | 2.14 Mn |
| Dec 31, 2019 | 98,120.00 |
| Jun 30, 2019 | 5.26 Mn |
| Jun 30, 2018 | 4.43 Mn |
| Dec 31, 2017 | 159,606.78 |
| Sep 28, 2017 | 159,606.78 |
| Aug 31, 2017 | 226,000.00 |
| Jun 30, 2017 | 226,000.00 |
| Dec 31, 2016 | 796,704.06 |